PMID- 26473312 OWN - NLM STAT- MEDLINE DCOM- 20170103 LR - 20170104 IS - 1365-2133 (Electronic) IS - 0007-0963 (Linking) VI - 174 IP - 3 DP - 2016 Mar TI - Propranolol in the treatment of infantile haemangiomas: lessons from the European Propranolol In the Treatment of Complicated Haemangiomas (PITCH) Taskforce survey. PG - 594-601 LID - 10.1111/bjd.14233 [doi] AB - BACKGROUND: Oral propranolol is widely prescribed as first-line treatment for infantile haemangiomas (IHs). Anecdotally, prescribing practice differs widely between centres. OBJECTIVES: The Propranolol In the Treatment of Complicated Haemangiomas (PITCH) Taskforce was founded to establish patterns of use of propranolol in IHs. METHODS: Participating centres entered data on all of their patients who had completed treatment with oral propranolol for IHs, using an online data capture tool. RESULTS: The study cohort comprised 1097 children from 39 centres in eight European countries. 76.1% were female and 92.8% had a focal IH, with the remainder showing a segmental, multifocal or indeterminate pattern. The main indications for treatment were periocular location (29.3%), risk of cosmetic disfigurement (21.1%) and ulceration and bleeding (20.6%). In total 69.2% of patients were titrated up to a maintenance regimen, which consisted of 2 mg kg(-1) per day (85.8%) in the majority of cases. 91.4% of patients had an excellent or good response to treatment. Rebound growth occurred in 14.1% upon stopping, of whom 53.9% were restarted and treatment response was recaptured in 91.6% of cases. While there was no significant difference in the treatment response, comparing a daily maintenance dose of < 2 mg kg(-1) vs. 2 mg kg(-1) vs. > 2 mg kg(-1) , the risk of adverse events was significantly higher: odds ratio (OR) 1 vs. adjusted OR 0.70, 95% confidence interval (CI) 0.33-1.50, P = 0.36 vs. OR 2.38, 95% CI 1.04-5.46, P = 0.04, Ptrend < 0.001. CONCLUSIONS: The PITCH survey summarizes the use of oral propranolol across 39 European centres, in a variety of IH phases, and could be used to inform treatment guidelines and the design of an interventional study. CI - (c) 2015 British Association of Dermatologists. FAU - Wedgeworth, E AU - Wedgeworth E AD - Department of Paediatric Dermatology, St John's Institute of Dermatology, Guy's and St Thomas' Hospitals NHS Foundation Trust, London, U.K. FAU - Glover, M AU - Glover M AD - Department of Paediatric Dermatology, Great Ormond Street Hospital NHS Foundation Trust, London, U.K. FAU - Irvine, A D AU - Irvine AD AD - National Children's Research Centre & Department of Paediatric Dermatology, Our Lady's Children's Hospital, Dublin, Ireland. FAU - Neri, I AU - Neri I AD - Dermatology Department of Experimental, Diagnostic and Specialty Medicine (DIMES), S. Orsola-Malpighi Hospital, Bologna University, Bologna, Italy. FAU - Baselga, E AU - Baselga E AD - Pediatric Dermatology Unit, Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. FAU - Clayton, T H AU - Clayton TH AD - Department of Paediatric Dermatology, Royal Manchester Children's Hospital, Manchester, U.K. FAU - Beattie, P E AU - Beattie PE AD - Department of Paediatric Dermatology, Royal Hospital for Children, Glasgow, U.K. FAU - Bjerre, J V AU - Bjerre JV AD - Department of Paediatrics, University Hospital Aarhus, Aarhus, Denmark. FAU - Burrows, N P AU - Burrows NP AD - Department of Dermatology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, U.K. FAU - Foelster-Holst, R AU - Foelster-Holst R AD - Department of Dermatology, University Hospital Schleswig-Holstein, Campus Kiel, Germany. FAU - Hedelund, L AU - Hedelund L AD - Department of Dermatology, University Hospital Aarhus, Aarhus, Denmark. FAU - Hernandez-Martin, A AU - Hernandez-Martin A AD - Department of Dermatology, Hospital Infantil Nino Jesus, Madrid, Spain. FAU - Audrain, H AU - Audrain H AD - Department of Paediatric Dermatology, University Hospitals Bristol NHS Foundation Trust, Bristol, U.K. FAU - Bhate, K AU - Bhate K AD - Department of Paediatric Dermatology, Nottingham Children's Hospital, Nottingham, U.K. FAU - Brown, S J AU - Brown SJ AD - Department of Dermatology, Ninewells Hospital and Medical School, Dundee, U.K. FAU - Baryschpolec, S AU - Baryschpolec S AD - Department of Dermatology, Portsmouth Hospitals NHS Trust, Portsmouth, U.K. FAU - Darne, S AU - Darne S AD - Department of Dermatology, South Tees Hospitals NHS Foundation Trust, Middlesbrough, U.K. FAU - Durack, A AU - Durack A AD - Department of Dermatology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, U.K. FAU - Dvorakova, V AU - Dvorakova V AD - National Children's Research Centre & Department of Paediatric Dermatology, Our Lady's Children's Hospital, Dublin, Ireland. FAU - Gach, J AU - Gach J AD - Department of Dermatology, University Hospitals Coventry and Warwickshire, Coventry, U.K. FAU - Goldstraw, N AU - Goldstraw N AD - Department of Dermatology, St George's University Hospitals NHS Foundation Trust, London, U.K. FAU - Goodyear, H AU - Goodyear H AD - Department of Paediatric Dermatology, Heart of England NHS Foundation Trust, Birmingham, U.K. FAU - Grabczynska, S AU - Grabczynska S AD - Department of Dermatology, Buckinghamshire Healthcare NHS Trust, Amersham, U.K. FAU - Greenblatt, D AU - Greenblatt D AD - Department of Dermatology, St George's University Hospitals NHS Foundation Trust, London, U.K. FAU - Halpern, J AU - Halpern J AD - Department of Dermatology, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, U.K. FAU - Hearn, R M R AU - Hearn RM AD - Department of Dermatology, Ninewells Hospital and Medical School, Dundee, U.K. FAU - Hoey, S AU - Hoey S AD - Department of Dermatology, Royal Victoria Hospital, Belfast, U.K. FAU - Hughes, B AU - Hughes B AD - Department of Dermatology, Portsmouth Hospitals NHS Trust, Portsmouth, U.K. FAU - Jayaraj, R AU - Jayaraj R AD - Department of Paediatrics, South Tees Hospitals NHS Foundation Trust, Middlesbrough, U.K. FAU - Johansson, E K AU - Johansson EK AD - Dermatological and Venereal Clinic, Sodersjukhuset, Stockholm, Sweden. FAU - Lam, M AU - Lam M AD - Department of Paediatric Dermatology, Nottingham Children's Hospital, Nottingham, U.K. FAU - Leech, S AU - Leech S AD - Department of Paediatric Dermatology, The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle, U.K. FAU - O'Regan, G M AU - O'Regan GM AD - National Children's Research Centre & Department of Paediatric Dermatology, Our Lady's Children's Hospital, Dublin, Ireland. FAU - Morrison, D AU - Morrison D AD - Department of Paediatric Ophthalmology, Guy's and St Thomas' Hospitals NHS Foundation Trust, London, U.K. FAU - Porter, W AU - Porter W AD - Department of Paediatric Dermatology, Gloucestershire Hospitals NHS Foundation Trust, Gloucester, U.K. FAU - Ramesh, R AU - Ramesh R AD - Department of Dermatology, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, U.K. FAU - Schill, T AU - Schill T AD - Departments of Paediatrics & Paediatric Dermatology, Catholic Children's Hospital Wilhelmstift, Hamburg, Germany. FAU - Shaw, L AU - Shaw L AD - Department of Paediatric Dermatology, University Hospitals Bristol NHS Foundation Trust, Bristol, U.K. FAU - Taylor, A E M AU - Taylor AE AD - Department of Paediatric Dermatology, The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle, U.K. FAU - Taylor, R AU - Taylor R AD - Department of Ophthalmology, York Teaching Hospital NHS Foundation Trust, York, U.K. FAU - Thomson, J AU - Thomson J AD - Department of Paediatric Dermatology, St John's Institute of Dermatology, Guy's and St Thomas' Hospitals NHS Foundation Trust, London, U.K. FAU - Tiffin, P AU - Tiffin P AD - Department of Ophthalmology, City Hospitals Sunderland NHS Foundation Trust, Sunderland, U.K. FAU - Tsakok, M AU - Tsakok M AD - Department of Dermatology, Oxford University Hospitals, Oxford, U.K. FAU - Janmohamed, S R AU - Janmohamed SR AD - Department of Dermatology, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Laarbeeklan 101, 1090, Brussels, Belgium. FAU - Laguda, B AU - Laguda B AD - Department of Paediatric Dermatology, Chelsea and Westminster Hospital NHS Foundation Trust, London, U.K. FAU - McPherson, T AU - McPherson T AD - Department of Dermatology, Oxford University Hospitals, Oxford, U.K. FAU - Oranje, A P AU - Oranje AP AD - Department of Dermatology (Paediatric Dermatology and Hair), Dermicis, Alkmaar and Foundation/Network for Pediatric Dermatology Rotterdam, Rotterdam, the Netherlands. FAU - Patrizi, A AU - Patrizi A AD - Dermatology Department of Experimental, Diagnostic and Specialty Medicine (DIMES), S. Orsola-Malpighi Hospital, Bologna University, Bologna, Italy. FAU - Ravenscroft, J C AU - Ravenscroft JC AD - Department of Paediatric Dermatology, Nottingham Children's Hospital, Nottingham, U.K. FAU - Shahidullah, H AU - Shahidullah H AD - Department of Dermatology, Derby NHS Foundation Trust, Derby, U.K. FAU - Solman, L AU - Solman L AD - Department of Paediatric Dermatology, Great Ormond Street Hospital NHS Foundation Trust, London, U.K. FAU - Svensson, A AU - Svensson A AD - Lund University, Institute of Clinical Research in Malmo, Skane University Hospital, Department of Dermatology, Malmo, Sweden. FAU - Wahlgren, C F AU - Wahlgren CF AD - Dermatology Unit, Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden. FAU - Hoeger, P H AU - Hoeger PH AD - Departments of Paediatrics & Paediatric Dermatology, Catholic Children's Hospital Wilhelmstift, Hamburg, Germany. FAU - Flohr, C AU - Flohr C AD - Department of Paediatric Dermatology, St John's Institute of Dermatology, Guy's and St Thomas' Hospitals NHS Foundation Trust, London, U.K. LA - eng GR - Department of Health/United Kingdom PT - Journal Article PT - Multicenter Study PT - Observational Study PT - Research Support, Non-U.S. Gov't DEP - 20151226 PL - England TA - Br J Dermatol JT - The British journal of dermatology JID - 0004041 RN - 0 (Antineoplastic Agents) RN - 9Y8NXQ24VQ (Propranolol) SB - IM MH - Administration, Oral MH - Antineoplastic Agents/*administration & dosage/adverse effects MH - Dose-Response Relationship, Drug MH - Female MH - Hemangioma/*drug therapy MH - Humans MH - Infant MH - Male MH - Propranolol/*administration & dosage/adverse effects MH - Skin Neoplasms/*drug therapy MH - Treatment Outcome EDAT- 2015/10/17 06:00 MHDA- 2017/01/04 06:00 CRDT- 2015/10/17 06:00 PHST- 2015/10/05 00:00 [accepted] PHST- 2015/10/17 06:00 [entrez] PHST- 2015/10/17 06:00 [pubmed] PHST- 2017/01/04 06:00 [medline] AID - 10.1111/bjd.14233 [doi] PST - ppublish SO - Br J Dermatol. 2016 Mar;174(3):594-601. doi: 10.1111/bjd.14233. Epub 2015 Dec 26.